Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 1/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | ECE1 | P42892 | 2/20 | 0.41 |
| ▸ | BMP1 | P13497 | 1/20 | 0.41 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.41 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5970089 | 1.00 | CTSC (0.47) | CTSCNOD1KMT2AALOX15BLM | |
| SCHEMBL8427081 | 1.00 | CTSC (0.47) | CTSCNOD1KMT2AALOX15BLM | |
| SCHEMBL2492391 | 1.00 | CTSC (0.47) | CTSCNOD1KMT2AALOX15BLM | |
| SCHEMBL8427089 | 1.00 | CTSC (0.47) | CTSCNOD1KMT2AALOX15BLM | |
| SCHEMBL30974391 | 0.93 | CTSC (0.51) | CTSCNOD1FOLH1BMP1NAALAD2 | |
| SCHEMBL29498236 | 0.92 | BACE1 (0.41) | CTSCNOD1KMT2ADPP4DPP8 | |
| SCHEMBL29766629 | 0.90 | CTSC (0.45) | CTSCNOD1KMT2AALOX15BLM | |
| SCHEMBL29873367 | 0.89 | CTSC (0.48) | CTSCFOLH1BMP1NAALAD2RIMKLA | |
| SCHEMBL29630635 | 0.89 | CTSC (0.44) | CTSCNOD1KMT2AALOX15BLM | |
| SCHEMBL10804587 | 0.89 | CTSC (0.58) | CTSCNOD1DPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119007832-B | Blood metabolism marker set for Alzheimer disease diagnosis and screening method and application thereof | 复旦大学 | 2025-04-04 | — | — | CN | claimed |
| CN-116675736-A | Synthetic method of polypeptide growth factor PSK | 杭州东恒生物医药有限公司 | 2023-09-01 | — | — | CN | claimed |
| US-20260036547-A1 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | ASTRAZENECA AB (SE) | 2026-02-05 | — | — | US | disclosed |
| US-20250388623-A1 | PEPTIDE INHIBITOR AND USE THEREOF | CHENGDU BRILLIANT INSPIRATION BIOTHERAPEUTICS CO LTD (CN) | 2025-12-25 | — | — | US | disclosed |
| US-20250295713-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2025-09-25 | — | — | US | disclosed |
| CN-120193029-A | Method for synthesizing chiral 2, 6-dimethyl-1-aminoindene serving as pesticide intermediate | 江苏扬农化工股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| WO-2025081445-A1 | CATCHER/TAG PEPTIDE LINKER WITH HIGH ESTER BOND FORMING EFFICIENCY | 南京工业大学 | 2025-04-24 | — | — | WO | disclosed |
| US-20240376160-A1 | MOLECULAR PEPTIDE MUTANT WITH A HIGH ESTER BOND FORMATION EFFICIENCY | NANJING TECH UNIVERSITY (CN) | 2024-11-14 | — | — | US | disclosed |
| US-12064459-B2 | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes | DERMBIONT, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| WO-2024132725-A1 | SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF INTRACRANIAL HEMORRHAGIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF INTRACRANIAL HEMORRHAGIC STROKE FROM ACUTE ISCHEMIC STROKE | UNIWERSYTET GDANSKI (PL) | 2024-06-27 | — | — | WO | disclosed |
| CN-116574741-B | PuHB gene for improving salt tolerance of populus euphratica, protein coded by same and application of PuHB gene | 沈阳农业大学 | 2024-06-18 | — | — | CN | disclosed |
| EP-1911839-B1 | Peptide-forming enzyme gene, peptide-forming enzyme, and dipeptide producing method | AJINOMOTO KK (JP) | 2011-10-26 | — | — | EP | disclosed |
| US-7618796-B2 | Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method | AJINOMOTO CO., INC. (JP) | 2009-11-17 | — | — | US | disclosed |
| EP-1411116-B1 | PEPTIDE SYNTHASE GENE, PEPTIDE SYNTHASE AND PROCESS FOR PRODUCING DIPEPTIDE | AJINOMOTO KK (JP) | 2008-04-23 | — | — | EP | disclosed |
| EP-1911839-A1 | Peptide-forming enzyme gene, peptide-forming enzyme, and dipeptide producing method | Ajinomoto Co., Inc. (JP) | 2008-04-16 | — | — | EP | disclosed |
| US-7288388-B2 | Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method | AJINOMOTO CO., INC. (JP) | 2007-10-30 | — | — | US | disclosed |
| US-20070048838-A1 | Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method | AJINOMOTO CO., INC (JP) | 2007-03-01 | — | — | US | disclosed |
| US-20060217321-A1 | Compositions to improve tic disorders | TAIYOKAGAKU CO., LTD. (JP) | 2006-09-28 | — | — | US | disclosed |
| US-20050037453-A1 | Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method | AJINOMOTO CO. INC (JP) | 2005-02-17 | — | — | US | disclosed |
| EP-1411116-A1 | PEPTIDE SYNTHASE GENE, PEPTIDE SYNTHASE AND PROCESS FOR PRODUCING DIPEPTIDE | Ajinomoto Co., Inc. (JP) | 2004-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388623-A1 | PEPTIDE INHIBITOR AND USE THEREOF | VIP, TGFB1, FN1 | CTSC 43/4885NOD1 1096/4885KMT2A 3904/4885 |
| US-20260036547-A1 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | ATP5ME, ATP5MF, ATP5MK | CTSC 746/4885NOD1 1134/4885KMT2A 4225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.